Revlimid Treatment and Use
Revlimid | lenalidomide is a drug marketed by Celgene that is used to treat multiple myeloma (cancer of the plasma cells) as well as myelodysplastic syndromes (MDS), specifically 5q MDS, a condition in which myeloid blood cells are produced inefficiently, which often evolves into a severe form of anemia that requires treatment by blood transfusions.
Revlimid | lenalidomide comes with serious precautions and warnings that should be reviewed by the patient in-depth before agreeing to treatment with this drug. If you are considering treatment with Revlimid | lenalidomide, you must familiarize yourself with these risks in order to make an informed decision. Ask your doctor any questions you may have about Revlimid, and ensure that your doctor knows your complete medical history.
Revlimid’s active ingredient is lenalidomide. Inactive ingredients include:
- Lactose anhydrous
- Microcrystalline cellulose
- Croscormellose sodium, and
- Magnesium stearate
Make sure that you are not allergic to any of Revlimid’s ingredients to prevent a severe reaction.
Revlimid Dosing
Revlimid | lenalidomide is only available in 28 day supplies. In order to get a refill, you must continue participation in the RevAssist program, designed to ensure that the patient continues to understand the risks of taking this medication while undergoing treatment.
Revlimid is to be taken once a day at the strength prescribed by your doctor with or without food, with a glass of water for a period of 21 days. After completion of the 21 day cycle, you will have a 7 day break, after which your next round of medication will start.
Participation in the RevAssist program is mandatory for continuing your treatment with Revlimid.
